About Gregory Ho
Gregory Ho is a director at Allyx Therapeutics. The company develops oral medicines designed to protect brain-cell connections in neurodegenerative disease.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Gregory Ho in the role, so the role may have started earlier or lasted longer.
Allyx Therapeutics, Inc. Current
Director
2021 – Present · New Haven, CT
A clinical-stage drug developer building oral treatments to protect brain-cell connections from neurodegenerative disease.
Key Colleagues at Startups
The people Gregory Ho works with at each company, as listed on that company's latest Form D.
Allyx Therapeutics, Inc. · Form D/A, Oct 21, 2026
SB
Stephen Bloch
CEO & Co-Founder, director
SS
Stephen Strittmatter
Scientific Founder and director
Paul Fonteyne
Co-Founder and director
RB
Robert Bettigole
Director
TS
Timothy Siegert
COO & Co-Founder
Kevin Rakin
Director